Home > Insider Trading > Filing (0001968202-23-000016)

Filing Details

Accession Number:: 0001968202-23-000016
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-07-06 16:01:43
Reporting Period:: 2023-07-03

Accepted Time:: 2023-07-06 16:01:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1187443	F Arthur Ryan	777 Old Saw Mill River Road Tarrytown NY 10591		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-07-03	1	$710.09	18,846	No	4	S	Direct
Common Stock	Disposition	2023-07-03	1	$711.95	18,845	No	4	S	Direct
Common Stock	Disposition	2023-07-03	6	$713.82	18,839	No	4	S	Direct
Common Stock	Disposition	2023-07-03	10	$714.65	18,829	No	4	S	Direct
Common Stock	Disposition	2023-07-03	7	$715.23	18,822	No	4	S	Direct
Common Stock	Disposition	2023-07-03	29	$716.74	18,793	No	4	S	Direct
Common Stock	Disposition	2023-07-03	22	$717.57	18,771	No	4	S	Direct
Common Stock	Disposition	2023-07-03	12	$718.71	18,759	No	4	S	Direct
Common Stock	Disposition	2023-07-03	11	$719.36	18,748	No	4	S	Direct
Common Stock	Disposition	2023-07-03	1	$720.15	18,747	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 4, 2022.
Represents volume-weighted average price of sales of 10 shares of Company stock on July 3, 2023 at prices ranging from $714.17 to $714.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price.
Represents volume-weighted average price of sales of 7 shares of Company stock on July 3, 2023 at prices ranging from $715.02 to $715.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price.
Represents volume-weighted average price of sales of 29 shares of Company stock on July 3, 2023 at prices ranging from $716.09 to $716.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price.
Represents volume-weighted average price of sales of 22 shares of Company stock on July 3, 2023 at prices ranging from $717.22 to $717.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price.
Represents volume-weighted average price of sales of 12 shares of Company stock on July 3, 2023 at prices ranging from $718.47 to $718.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price.
Represents volume-weighted average price of sales of 11 shares of Company stock on July 3, 2023 at prices ranging from $719.05 to $719.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price.